Houston – Harris County Public Health (HCPH) is pleased to announce that there is a new option for people to get their COVID19 vaccine. On July 13, 2022, the U.S. Food and Drug Administration (FDA) authorized the Novavax COVID-19 Vaccine for emergency use. Following approvals of the Centers for Disease Control and Prevention (CDC) and Texas Department of State Health Services (DSHS), HCPH is now offering the COVID-19 Novavax vaccine to residents. Novavax is a two-dose primary series for individuals 18 years of age and older given 3 weeks apart.
Novavax uses a different technique than other COVID-19 vaccines such as those from Pfizer and Moderna. Instead of using mRNA, which provides the instructions for your body to create the COVID-19 spike protein that in turn induces your body’s immune response, Novavax’s vaccine injects the small protein itself, that your body detects and that triggers your body’s immune response. The Novavax vaccine is based on a well-established method of vaccine development that has been used for years for other vaccines such as the Human-papillomavirus, Hepatitis B, flu, and Shingles vaccines.